Treatment of acquired von Willebrand syndrome with intravenous immunoglobulin.
Arkel
Y S
YS
Lynch
J
J
Kamiyama
M
M
D001327:Autoimmune Diseases / Q000628:therapy*; D001760:Bleeding Time; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D014842:von Willebrand Diseases / Q000276:immunology / Q000628:therapy*
D016756:Immunoglobulins, Intravenous